Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows from Operating Activities    
Net income $ 80,402 $ 71,761
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 11,673 12,040
Share-based compensation expense 1,145 783
Non-cash operating lease cost 22,557 22,505
Deferred income taxes (2,110) 1,709
Restructuring and other impairment charges, net of gains (2,662) (4,841)
Restructuring payments (1,020) (1,144)
Loss on disposal of property, plant and equipment 43 25
Other 513 23
Change in operating assets and liabilities    
Accounts receivable, net 1,202 (2,523)
Inventories, net 24,849 (38,711)
Prepaid expenses and other current assets 3,757 (3,551)
Customer deposits (28,308) 5,790
Accounts payable and accrued expenses (9,319) 5,330
Accrued compensation and benefits (1,634) (3,690)
Operating lease liabilities (23,355) (25,027)
Other assets and liabilities (3,375) (478)
Net cash provided by operating activities 74,358 40,001
Cash Flows from Investing Activities    
Proceeds from sales of property, plant and equipment 8,105 10,613
Capital expenditures (10,679) (9,031)
Purchases of investments (189,951) (18,521)
Proceeds from sales of investments 106,933 9,000
Net cash used in investing activities (85,592) (7,939)
Cash Flows from Financing Activities    
Payment of cash dividends (37,183) (40,114)
Proceeds from employee stock plans 75 1,096
Taxes paid related to net share settlement of equity awards (812) (843)
Payments on financing leases (395) (389)
Other financing costs 28 (505)
Net cash used in financing activities (38,287) (40,755)
Effect of exchange rate changes on cash and cash equivalents 27 43
Net decrease in cash, cash equivalents and restricted cash (49,494) (8,650)
Cash, cash equivalents and restricted cash at beginning of period 110,871 104,596
Cash, cash equivalents and restricted cash at end of period $ 61,377 $ 95,946